Nuformix (FRA:1RT) Other Current Liabilities: €0.00 Mil (As of Mar. 2026)


What is Nuformix Other Current Liabilities?

Nuformix FRA:1RT +200.00% Other Current Liabilities is €0.00 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Nuformix's other current liabilities for the quarter that ended in Mar. 2026 was €0.00 Mil.

Nuformix's quarterly other current liabilities increased from Mar. 2025 (€0.00 Mil) to Sep. 2025 (€0.25 Mil) but then declined from Sep. 2025 (€0.25 Mil) to Mar. 2026 (€0.00 Mil).

Nuformix's annual other current liabilities increased from Mar. 2023 (€0.00 Mil) to Sep. 2024 (€0.26 Mil) but then declined from Sep. 2024 (€0.26 Mil) to Sep. 2025 (€0.25 Mil).

Nuformix Other Current Liabilities Related Terms

Nuformix Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Nuformix's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuformix Other Current Liabilities Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24 Sep25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.26 0.00 0.26 0.25

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.26 0.00 0.25 0.00

Nuformix Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €0.00 Mil mean?
Nuformix (FRA:1RT) has a Other Current Liabilities of €0.00 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Nuformix.
Is Nuformix's Other Current Liabilities too high?
Nuformix's current Other Current Liabilities is €0.00 Mil.
How does Nuformix's Other Current Liabilities compare to VRTX and REGN?
Nuformix's Other Current Liabilities of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Nuformix. Nuformix's current Other Current Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuformix stock overvalued right now?
Nuformix (FRA:1RT) has a current Other Current Liabilities of €0.00 Mil. The current Other Current Liabilities is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Nuformix (FRA:1RT), the current Other Current Liabilities is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuformix Business Description

Other Exchanges NFX:UK1RT:Germany
Address C/O Arch Law Limited, 8 Bishopsgate, Huckletree Bishopsgate, London, GBR, EC2N 4BQ
Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.